NCT07786415

Brief Summary

This study aims to explore the relationship between spinal alignment and functional performance in individuals with upper cross syndrome following a combined breathing and manual therapy program. It is designed as a secondary analysis of data obtained from a previously conducted randomized controlled trial, with the addition of objective spinal measurements using the Spinal Mouse device. Functional performance will be assessed using standardized tests such as the 6-minute walk test and the timed up and go test. Statistical analysis will include correlation and regression models to determine whether spinal alignment parameters can predict functional outcomes. The findings are expected to provide insight into the biomechanical role of posture in functional recovery among individuals with upper cross syndrome.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Aug 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Aug 2026Oct 2026

First Submitted

Initial submission to the registry

August 19, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

August 25, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2026

Last Updated

August 26, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

August 19, 2026

Last Update Submit

August 21, 2026

Conditions

Keywords

upper cross syndromeSpinal alignmentFunctional performance

Outcome Measures

Primary Outcomes (2)

  • Spinal Alignment: Thoracic kyphosis

    Kyphosis is the forward curvature of the thoracic spine.It will be measured by The Spinal Mouse ( a hand-held, computer-assisted medical device used to measure spinal curvature, posture, and segmental mobility without radiation )

    Pre and post 8 weeks

  • Spinal Alignment: Lumbar lordosis

    inward curvature of the spine when this curve becomes excessive or diminished, it can lead to discomfort and postural issues.It will be measured by The Spinal Mouse ( a hand-held, computer-assisted medical device used to measure spinal curvature, posture, and segmental mobility without radiation )

    Pre and post 8 weeks

Secondary Outcomes (2)

  • Functional Performance: 6-Minute Walk Test (6MWT)

    Pre and post 8 weeks

  • Functional Performance: Timed Up and Go Test (TUG)

    Pre and post 8 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL
Other: The experimental group will perform ujjayi pranayama and osteopathic manipulative tratment

Control group

ACTIVE COMPARATOR
Other: control group will perform osteopathic manipulative treatment only

Interventions

The experimental group will perform ujjayi pranayama and osteopathic manipulative treatment for 45 min sessions, 5 times a week for 8 weeks

Experimental group

control group will perform osteopathic manipulative treatment only for 45 min sessions, 5 times a week for 8 weeks

Control group

Eligibility Criteria

Age20 Years - 29 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Full time college students of age 20-29 years.
  • Subjects who have upper cross syndrome according to REEDCO posture assessment.
  • Subjects who not receiving medical treatment for respiratory diseases .
  • Subjects who have clean family medical history.

You may not qualify if:

  • Subjects who engaged in additional exercise in two weeks, which was likely to affect the results of the research .
  • Individuals with a history of spine, shoulder fractures, surgery, or other disease.
  • Individuals with severe cardia-cerebrovascular disease.
  • Individuals who will have difficulty to follow-up testing).
  • Neurologic and psychiatric disorders (who can not understand the research project ).
  • Individuals with congenital deformities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Oculocerebral hypopigmentation syndrome type Preus

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor doctor

Study Record Dates

First Submitted

August 19, 2026

First Posted

August 26, 2026

Study Start

August 25, 2026

Primary Completion (Estimated)

October 25, 2026

Study Completion (Estimated)

October 25, 2026

Last Updated

August 26, 2026

Record last verified: 2026-08